StockDuty ← Dashboard Nov 11, 2026 06:57 AM ET
SignalEU/UK

Labcorp Holdings Inc. (LH) Presents at 2026 UBS Global Healthcare Conference Transcript

High-priority alert based on source significance and keyword relevance.

What happened: Labcorp CFO Julia Wang spoke at the 2026 UBS Global Healthcare Conference in a Q&A with UBS analyst Kevin Caliendo, discussing the company's recent quarterly performance. Key numbers: Revenue grew 7%, margin expanded 60 basis points, adjusted EPS grew 14.5%, and organic growth was 5.5%, described as the sixth straight quarter of margin Why it matters: The analyst noted the quarter was one of the company's best prints in years, with organic growth up sequentially even though utilization trackers were not necessarily better, which he said may suggest Labcorp took share.
Labcorp CFO Julia Wang spoke at the 2026 UBS Global Healthcare Conference in a Q&A with UBS analyst Kevin Caliendo, discussing the company's recent quarterly performance.
The analyst noted the quarter was one of the company's best prints in years, with organic growth up sequentially even though utilization trackers were not necessarily better, which he said may suggest Labcorp took share.
Sources